Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesSANUWAVE Health, Inc. Common Stock

SANUWAVE Health, Inc. Common Stock

Healthcare Medical Devices
PortfolioPortfolio WatchlistWatchlist
Company price
2.19 USD -0.06 ( 2.67%)
Last update at 2026-11-06T21:00:00Z
VOLUME
361041
Market Cap
35.36M
P/E
5.27

Momentum Score

…

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
2.10
Low
2.65
High
52 Week Price Range
3.92
Low
40.87
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

SANUWAVE Health, Inc. develops and commercializes a non-invasive pulsed acoustic shockwave platform aimed at promoting tissue repair, with primary focus on chronic wound care and related soft-tissue indications. Long-term growth drivers include rising diabetes and chronic-wound prevalence, expansion of clinical evidence and regulatory/reimbursement progress, and potential commercialization partnerships that could support wider adoption.
Key risks include limited scale and financial resources, reliance on a single technology and commercialization execution, regulatory and reimbursement uncertainty, and strong competition in wound care that could constrain revenue and require additional financing.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
2.25
Dividend Yield
-
Revenue TTM
44.02M
Revenue Per Share
5.13
Gross Profit TTM
33.60M
Debt / Equity
14.19
ROE
-
Net Debt
11.01M
ROCE
93.07%
Diluted EPS TTM
0.78

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Income before tax 11.90M -31.34M -25.80M -10.29M -30.94M
Net income 11.81M -31.37M -25.81M -10.29M -34.08M
Selling general administrative 19.37M 11.35M 8.67M 12.56M 13.72M
Selling and marketing expenses 7.42M 6.32M 4.90M 7.47M 5.16M
Gross profit 33.97M 24.55M 14.36M 12.41M 2.90M
Reconciled depreciation 1.28M 1.15M 1.05M 0.95M 1.24M
Ebit 18.14M -17.71M -10.18M -8.95M -18.01M
Ebitda 19.43M -16.56M -9.15M -11.43M -16.40M
Depreciation and amortization 1.28M 1.15M 1.03M -2.48M 1.61M
Operating income 4.95M 5.42M -0.54M -8.95M -18.01M
Other operating expenses 39.11M 27.22M 20.94M 25.69M 22.07M
Interest expense 6.25M 13.64M 15.62M 14.13M 2.54M
Tax provision 0.09M 0.03M 0.00M 0.00M 0.03M
Net interest income -6.25M -13.78M -16.66M -17.57M -10.67M
Income tax expense 0.09M 0.03M 0.00M 0.00M 3.14M
Total revenue 44.05M 32.63M 20.40M 16.74M 4.06M
Total operating expenses 29.02M 19.13M 14.90M 21.36M 20.91M
Cost of revenue 10.08M 8.08M 6.04M 4.33M 1.16M
Total other income expense net 6.95M -36.76M -25.26M -1.34M -12.92M
Net income from continuing ops 11.81M -33.08M -49.74M -10.29M -27.26M
Net income applicable to common shares - - - - -27.26M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Total assets 37.34M 30.12M 22.42M 19.87M 23.03M
Intangible assets 3.03M 3.73M 4.43M 5.14M 6.55M
Other current assets 1.31M 0.68M 1.72M 0.57M 0.18M
Total liab 35.72M 42.84M 65.59M 60.88M 36.75M
Total stockholder equity 1.62M -12.72M -43.18M -41.01M -13.72M
Other current liab 8.45M 13.12M 27.51M 15.06M 14.64M
Common stock 0.01M 0.01M 1.14M 0.55M 0.47M
Capital stock 0.01M 0.01M 1.14M 0.55M 0.48M
Retained earnings -242.69M -251.42M -220.05M -194.24M -156.69M
Other liab - - - - 0.32M
Good will 7.26M 7.26M 7.26M 7.26M 7.26M
Other assets - - - - 0.11M
Cash 11.96M 10.24M 1.80M 1.15M 2.44M
Total current liabilities 17.85M 42.34M 64.75M 60.19M 36.17M
Current deferred revenue 0.39M 0.19M 0.09M 0.06M 0.03M
Net debt 11.01M 15.26M 30.15M 39.95M 15.14M
Short term debt 5.79M 25.30M 31.45M 40.67M 17.04M
Short long term debt 5.64M 25.30M 29.96M 40.67M 24.94M
Short long term debt total 22.97M 25.50M 31.94M 41.11M 17.58M
Other stockholder equity 244.28M 238.69M 175.84M 152.75M 142.56M
Property plant equipment - - - - 1.01M
Total current assets 24.63M 18.40M 9.78M 6.62M 7.93M
Net tangible assets - - - - -52.06M
Net receivables 5.42M 3.33M 3.31M 4.03M 2.36M
Long term debt 16.32M - - - 0.88M
Inventory 5.93M 4.15M 2.95M 0.87M 2.96M
Accounts payable 3.22M 3.73M 5.71M 4.40M 4.45M
Accumulated other comprehensive income 0.01M 0.01M -0.11M -0.07M -0.06M
Non currrent assets other 0.07M - -36.74M 0.11M 0.03M
Non current assets total 12.72M 11.72M 12.63M 13.25M 15.10M
Capital lease obligations 1.01M 0.49M 0.49M 0.44M 0.39M
Breakdown 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Type yearly yearly yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Investments - -0.49M -0.85M 0.33M -0.53M
Change to liabilities - - - - 3.26M
Total cashflows from investing activities 3.43M -0.49M 0.02M - -0.53M
Net borrowings -5.77M -2.46M 5.85M - 5.12M
Total cash from financing activities -5.59M 6.35M 5.21M 17.38M 33.45M
Change to operating activities - - - - 3.43M
Net income 11.81M -31.37M -25.81M -10.29M -30.94M
Change in cash 1.72M 8.44M 0.64M 0.53M 0.68M
Begin period cash flow 10.24M 1.80M 1.15M 0.62M 1.76M
End period cash flow 11.96M 10.24M 1.80M 1.15M 2.44M
Total cash from operating activities 3.88M 2.46M -4.54M -17.17M -12.72M
Issuance of capital stock 0.00M 10.30M 0.00M - 0.00M
Depreciation 1.28M 1.15M 1.03M 0.95M 1.01M
Other cashflows from investing activities 5.38M - 0.02M - -
Change to inventory -2.28M -1.20M -2.80M -0.07M -0.55M
Change to account receivables -2.30M -0.49M -0.05M -1.75M -2.58M
Other cashflows from financing activities -0.37M -1.49M -0.64M 20.60M 17.59M
Change to netincome - - - - 8.18M
Capital expenditures 1.94M 0.49M 0.00M 1.02M 0.05M
Change in working capital -4.01M -2.90M -3.61M -1.12M 1.37M
Stock based compensation 4.85M 1.51M 0.22M -0.47M 0.02M
Other non cash items -5.21M 34.07M 23.84M -6.24M 4.57M
Free cash flow 1.93M 1.97M -4.54M -16.15M -12.77M

Peer Comparison*

Sector: Healthcare Industry: Medical Devices

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
SNWV
SANUWAVE Health, Inc. Common Stock		 -0.06
2.67%		 2.19 5.27 18.25 0.80 13.23 1.09 2.39
ABT
Abbott Laboratories		 -0.03
0.03%		 109.93 25.97 17.24 3.57 3.20 3.81 16.75
MDT
Medtronic PLC		 -3.04
2.90%		 101.80 26.60 15.87 3.35 2.08 3.90 14.12
SYK
Stryker Corporation		 -9.21
2.75%		 325.87 29.23 16.86 4.18 4.51 4.63 17.16
SEMHF
Siemens Healthineers AG		 -2.15
4.12%		 49.85 39.57 21.32 3.01 3.29 2.95 16.92

Profile*

SANUWAVE Health, Inc. Common Stock

SANUWAVE Health, Inc. operates as a medical device company in the United States and internationally. It focuses on the commercialization of regenerative medicines through noninvasive ultrasound or shockwaves to produce a biological response promoting the repair and regeneration of tissue, musculoskeletal, and vascular structures. The company markets UltraMist system, a medical device that uses non-thermal ultrasound to treat tissues using a fluid mist to transmit energy in a non-contact and pain free way for use in the treatment of acute and chronic wounds. The company was founded in 2004 and is headquartered in Eden Prairie, Minnesota.

9600 W. 76th Street, Eden Prairie, MN, United States, 55344

952 656 1029

https://sanuwave.com

55

Name Title Year Born
Mr. Kevin A. Richardson II CEO & Director 1968
Mr. Peter Stegagno Chief Operation Officer 1960
Ms. Lisa E. Sundstrom Chief Talent Officer 1969
Dr. Toni Rinow M.B.A., MBA., Ph.D. Chief Financial Officer 1965
Dr. Iulian Cioanta Chief Science & Technology Officer 1963
Mr. Jack Schlechtweg Chief Revenue Officer 1980
Mr. Morgan C. Frank CEO & Chairman 1972
Mr. Daniel Coyle Chief Operating Officer 1991
Mr. Timothy Wern Executive Vice President of Sales - U.S. Wound 1968
Mr. Peter Sorensen CFO & Secretary 1993

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ITH
CAD 2.15
+27.68%
HG
CAD 4.11
+19.13%
PPTA
CAD 27.74
+17.99%
UCU
CAD 2.10
+17.32%
GAU
CAD 3.49
+16.72%
TSU
CAD 29.67
-29.71%
PXT
CAD 19.73
-16.91%
LAS-A
CAD 230.50
-9.25%
IFP
CAD 13.50
-8.35%
NFI
CAD 24.01
-7.80%

Equity Sectors*

  • Basic Materials

    +3.74%

  • Communication Services

    +0.56%

  • Consumer Cyclical

    -0.34%

  • Consumer Defensive

    +0.11%

  • Energy

    +1.33%

  • Financial Services

    -0.26%

  • Healthcare

    +2.54%

  • Industrials

    -0.11%

  • Real Estate

    -0.23%

  • Technology

    +1.91%

  • Utilities

    +1.05%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…